Skip to main content

The Role of Cytokines in the Mechanism of Adverse Drug Reactions

  • Chapter
  • First Online:
Adverse Drug Reactions

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 196))

Abstract

Cytokines are thought to play a role in acute and/or immune-mediated adverse drug reactions (ADRs) due to their ability to regulate the innate and adaptive immune systems. This role is highly complex owing to the pluripotent nature of cytokines, which enables the same cytokine to play multiple roles depending on target organ(s) involved. As a result, the discussion of cytokine involvement in ADRs is organized according to target organ(s); specifically, ADRs targeting skin and liver, as well as ADRs targeting multiple organs, such as drug-induced autoimmunity and infusion-related reactions. In addition to discussing the mechanism(s) by which cytokines contribute to the initiation, propagation, and resolution of ADRs, we also discuss the usefulness and limitations of current methodologies available to conduct such mechanistic studies. While animal models appear to hold the most promise for uncovering additional mechanisms, this field is plagued by a lack of good animal models and, as a result, the mechanism of cytokine involvement in ADRs is often studied using less informative in vitro studies. The recent formation of the Drug-Induced Liver Injury Network, whose goal is collect thousands of samples from drug-induced liver injury patients, has enormous potential to advance knowledge in this field, by enabling large-scale cytokine polymorphism studies. In conclusion, we discuss how further advances in this field could be of significant benefit to patients in terms of preventing, predicting, and treating ADRs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aarvak T, Chabaud M, Miossec P, Natvig JB (1999) IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 162:1246-1251

    PubMed  CAS  Google Scholar 

  • Ackerman Z, Levy M (1987) Hypersensitivity reactions to drugs in acquired immunodeficiency syndrome. Postgrad Med J 63:55-56

    PubMed  CAS  Google Scholar 

  • Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, Kenna JG, Caldwell J, Day CP (2004) Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39:1430-1440

    PubMed  CAS  Google Scholar 

  • Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y (2005) Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129:969-984

    PubMed  CAS  Google Scholar 

  • Antunez C, Martin E, Cornejo-Garcia JA, Blanca-Lopez N, RP R, Mayorga C, Torres MJ, Blanca M (2006) Immediate hypersensitivity reactions to penicillins and other betalactams. Curr Pharm Des 12:3327-3333

    PubMed  CAS  Google Scholar 

  • Baugh JA, Bucala R (2002) Macrophage migration inhibitory factor. Crit Care Med 30:S27-S35

    CAS  Google Scholar 

  • Bautista AP (1997) Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver. Hepatology 25:335-342

    PubMed  CAS  Google Scholar 

  • Benghiat FS, Charbonnier LM, Vokaer B, De Wilde V, Le Moine A (2009) Interleukin 17-producing T helper cells in alloimmunity. Transplant Rev (Orlando) 23:11-18

    Google Scholar 

  • Bernal W, Donaldson P, Underhill J, Wendon J, Williams R (1998) Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. J Hepatol 29:53-59

    PubMed  CAS  Google Scholar 

  • Beyer HS, Stanley M (1990) Tumor necrosis factor-alpha increases hepatic DNA and RNA and hepatocyte mitosis. Biochem Int 22:405-410

    PubMed  CAS  Google Scholar 

  • Bienvenu J, Chvetzoff R, Salles G, Balter C, Tilly H, Herbrecht R, Morel P, Lederlin P, Solal-Celigny P, Audhuy B, Christian B, Gabarre J, Casasnovas O, Marit G, Sebban C, Coiffier B (2001) Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J 2:378-384

    PubMed  CAS  Google Scholar 

  • Bissell DM, Gores GJ, Laskin DL, Hoofnagle JH (2001) Drug-induced liver injury: mechanisms and test systems. Hepatology 33:1009-1013

    PubMed  CAS  Google Scholar 

  • Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI (1995) Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133:43-52

    PubMed  CAS  Google Scholar 

  • Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, Croker BP, Morel L (2006) IL-10 regulation of lupus in the NZM2410 murine model. Lab Invest 86:1136-1148

    PubMed  CAS  Google Scholar 

  • Boess F, Bopst M, Althaus R, Polsky S, Cohen SD, Eugster HP, Boelsterli UA (1998) Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice. Hepatology 27:1021-1029

    PubMed  CAS  Google Scholar 

  • Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174:1549-1555

    PubMed  CAS  Google Scholar 

  • Bourdi M, Amouzadeh HR, Rushmore TH, Martin JL, Pohl LR (2001) Halothane-induced liver injury in outbred guinea pigs: role of trifluoroacetylated protein adducts in animal susceptibility. Chem Res Toxicol 14:362-370

    PubMed  CAS  Google Scholar 

  • Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, Pohl LR (2002a) Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35:289-298

    PubMed  CAS  Google Scholar 

  • Bourdi M, Reilly TP, Elkahloun AG, George JW, Pohl LR (2002b) Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness. Biochem Biophys Res Commun 294:225-230

    PubMed  CAS  Google Scholar 

  • Bourdi M, Eiras DP, Holt MP, Webster MR, Reilly TP, Welch KD, Pohl LR (2007) Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury. Chem Res Toxicol 20:208-216

    PubMed  CAS  Google Scholar 

  • Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, Burkhart C, Yawalkar N, Pichler WJ (2001) T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 107:1433-1441

    PubMed  CAS  Google Scholar 

  • Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y, Bendelac A (1999) Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163:4647-4650

    PubMed  CAS  Google Scholar 

  • Carr DF, Alfirevic A, Tugwood JD, Barratt BJ, Sherwood J, Smith J, Pirmohamed M, Park BK (2007) Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity. Pharmacogenet Genom 17:961-972

    CAS  Google Scholar 

  • Cattell V, Lianos E, Largen P, Cook T (1993) Glomerular NO synthase activity in mesangial cell immune injury. Exp Nephrol 1:36-40

    PubMed  CAS  Google Scholar 

  • Chaouchi N, Wallon C, Taieb J, Auffredou MT, Tertian G, Lemoine FM, Delfraissy JF, Vazquez A (1994) Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc. Clin Immunol Immunopathol 73:197-204

    PubMed  CAS  Google Scholar 

  • Chen M, Gandolfi J (1997) Characterization of the humoral immune response and hepatotoxicity after multiple halothane exposures in guinea pigs. Drug Metab Rev 29:103-122

    PubMed  CAS  Google Scholar 

  • Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD, Wynn TA (2001) Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 34:273-282

    PubMed  CAS  Google Scholar 

  • Chiu H, Brittingham JA, Laskin DL (2002) Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: effects of hemin and biliverdin. Toxicol Appl Pharmacol 181:106-115

    PubMed  CAS  Google Scholar 

  • Choquet-Kastylevsky G, Intrator L, Chenal C, Bocquet H, Revuz J, Roujeau JC (1998) Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol 139:1026-1032

    PubMed  CAS  Google Scholar 

  • Clynes RA, Towers TL, Presta LG, Ravetch JV (2000) Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med 6:443-446

    PubMed  CAS  Google Scholar 

  • Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379-1383

    PubMed  CAS  Google Scholar 

  • Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-748

    PubMed  CAS  Google Scholar 

  • Cumberbatch M, Dearman RJ, Antonopoulos C, Groves RW, Kimber I (2001) Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology 102:323-330

    PubMed  CAS  Google Scholar 

  • Dambach DM, Watson LM, Gray KR, Durham SK, Laskin DL (2002) Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35:1093-1103

    PubMed  CAS  Google Scholar 

  • Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfati M, Hofstetter H, Kilcherr E, Debre P, Dalloul A (1991) Expression, structure, and function of the CD23 antigen. Adv Immunol 49:149-191

    PubMed  CAS  Google Scholar 

  • Devalaraja MN, McClain CJ, Barve S, Vaddi K, Hill DB (1999) Increased monocyte MCP-1 production in acute alcoholic hepatitis. Cytokine 11:875-881

    PubMed  CAS  Google Scholar 

  • Diehl AM (2000) Cytokine regulation of liver injury and repair. Immunol Rev 174:160-171

    PubMed  CAS  Google Scholar 

  • Diehl AM, Rai RM (1996) Liver regeneration 3: Regulation of signal transduction during liver regeneration. FASEB J 10:215-227

    PubMed  CAS  Google Scholar 

  • DiPietro LA (1995) Wound healing: the role of the macrophage and other immune cells. Shock 4:233-240

    PubMed  CAS  Google Scholar 

  • Donker AJ, Venuto RC, Vladutiu AO, Brentjens JR, Andres GA (1984) Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin Immunol Immunopathol 30:142-155

    PubMed  CAS  Google Scholar 

  • Enzenauer RJ, West SG, Rubin RL (1990) D-penicillamine-induced lupus erythematosus. Arthritis Rheum 33:1582-1585

    PubMed  CAS  Google Scholar 

  • Finck BK, Chan B, Wofsy D (1994) Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 94:585-591

    PubMed  CAS  Google Scholar 

  • Fong TA, Mosmann TR (1989) The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J Immunol 143:2887-2893

    PubMed  CAS  Google Scholar 

  • Fournie GJ, Cautain B, Xystrakis E, Damoiseaux J, Mas M, Lagrange D, Bernard I, Subra JF, Pelletier L, Druet P, Saoudi A (2001) Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases. Immunol Rev 184:145-160

    PubMed  CAS  Google Scholar 

  • Friedmann PS, Strickland I, Pirmohamed M, Park BK (1994) Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 130:598-604

    PubMed  CAS  Google Scholar 

  • Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65-70

    PubMed  CAS  Google Scholar 

  • Ganey PE, Luyendyk JP, Maddox JF, Roth RA (2004) Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor. Chem Biol Interact 150:35-51

    PubMed  CAS  Google Scholar 

  • Gao B (2005) Cytokines, STATs and liver disease. Cell Mol Immunol 2:92-100

    PubMed  CAS  Google Scholar 

  • Gao PS, Mao XQ, Jouanguy E, Pallier A, Doffinger R, Tanaka Y, Nakashima H, Otsuka T, Roberts MH, Enomoto T, Dake Y, Kawai M, Sasaki S, Shaldon SR, Coull P, Adra CN, Niho Y, Casanova JL, Shirakawa T, Hopkin JM (1999) Nonpathogenic common variants of IFNGR1 and IFNGR2 in association with total serum IgE levels. Biochem Biophys Res Commun 263:425-429

    PubMed  CAS  Google Scholar 

  • Gardner CR, Laskin JD, Dambach DM, Chiu H, Durham SK, Zhou P, Bruno M, Gerecke DR, Gordon MK, Laskin DL (2003) Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol Appl Pharmacol 192:119-130

    PubMed  CAS  Google Scholar 

  • Geddes R (2007) Minocycline-induced lupus in adolescents: clinical implications for physical therapists. J Orthop Sports Phys Ther 37:65-71

    PubMed  Google Scholar 

  • Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP (2000) Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 46:540-545

    PubMed  CAS  Google Scholar 

  • Groves RW, Allen MH, Ross EL, Barker JN, MacDonald DM (1995) Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 132:345-352

    PubMed  CAS  Google Scholar 

  • Guglielmi L, Fontaine C, Gougat C, Avinens O, Eliaou JF, Guglielmi P, Demoly P (2006a) IL-10 promoter and IL4-Ralpha gene SNPs are associated with immediate beta-lactam allergy in atopic women. Allergy 61:921-927

    PubMed  CAS  Google Scholar 

  • Guglielmi L, Guglielmi P, Demoly P (2006b) Drug hypersensitivity: epidemiology and risk factors. Curr Pharm Des 12:3309-3312

    PubMed  CAS  Google Scholar 

  • Gunawan BK, Kaplowitz N (2007) Mechanisms of drug-induced liver disease. Clin Liver Dis 11:459-475, v

    Google Scholar 

  • Gutierrez A, Rodriguez J, Martinez J, Amezaga R, Ramos R, Galmes B, Bea MD, Ferrer J, Pons J, Sampol A, Morey M, Duran MA, Raurich J, Besalduch J (2006) Pathogenic study of anti-CD20 infusion-related severe refractory shock in diffuse large B-cell lymphoma. Leuk Lymphoma 47:111-115

    PubMed  CAS  Google Scholar 

  • Happ MP, Wettstein P, Dietzschold B, Heber-Katz E (1988) Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. J Immunol 141:1489-1494

    PubMed  CAS  Google Scholar 

  • Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K (2007) IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol 178:3822-3830

    PubMed  CAS  Google Scholar 

  • Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA (1997) The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337:1720-1725

    PubMed  CAS  Google Scholar 

  • Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ (1992) Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 119:547-552

    PubMed  CAS  Google Scholar 

  • Hogaboam CM, Simpson KJ, Chensue SW, Steinhauser ML, Lukacs NW, Gauldie J, Strieter RM, Kunkel SL (1999) Macrophage inflammatory protein-2 gene therapy attenuates adenovirus- and acetaminophen-mediated hepatic injury. Gene Ther 6:573-584

    PubMed  CAS  Google Scholar 

  • Hogaboam CM, Bone-Larson CL, Steinhauser ML, Matsukawa A, Gosling J, Boring L, Charo IF, Simpson KJ, Lukacs NW, Kunkel SL (2000) Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am J Pathol 156:1245-1252

    PubMed  CAS  Google Scholar 

  • Huang YH, Shi MN, Zheng WD, Zhang LJ, Chen ZX, Wang XZ (2006) Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats. World J Gastroenterol 12:1386-1391

    PubMed  CAS  Google Scholar 

  • Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M (1994) Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310

    PubMed  CAS  Google Scholar 

  • Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N (2002) A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 16:1227-1236

    PubMed  CAS  Google Scholar 

  • Ishida Y, Kondo T, Tsuneyama K, Lu P, Takayasu T, Mukaida N (2004) The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice. J Leukoc Biol 75:59-67

    PubMed  CAS  Google Scholar 

  • Jacob CO, Hwang F, Lewis GD, Stall AM (1991) Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation. Cytokine 3:551-561

    PubMed  CAS  Google Scholar 

  • James LP, Lamps LW, McCullough S, Hinson JA (2003) Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem Biophys Res Commun 309:857-863

    PubMed  CAS  Google Scholar 

  • James LP, Kurten RC, Lamps LW, McCullough S, Hinson JA (2005a) Tumour necrosis factor receptor 1 and hepatocyte regeneration in acetaminophen toxicity: a kinetic study of proliferating cell nuclear antigen and cytokine expression. Basic Clin Pharmacol Toxicol 97:8-14

    PubMed  CAS  Google Scholar 

  • James LP, Simpson PM, Farrar HC, Kearns GL, Wasserman GS, Blumer JL, Reed MD, Sullivan JE, Hinson JA (2005b) Cytokines and toxicity in acetaminophen overdose. J Clin Pharmacol 45:1165-1171

    PubMed  CAS  Google Scholar 

  • Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P (2003) Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol 30:2287-2291

    PubMed  Google Scholar 

  • Jaruga B, Hong F, Sun R, Radaeva S, Gao B (2003) Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 171:3233-3244

    PubMed  CAS  Google Scholar 

  • Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, George JW, Pohl LR (2002) Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol 15:1504-1513

    PubMed  CAS  Google Scholar 

  • Kaplowitz N, Tsukamoto H (1996) Oxidative stress and liver disease. Prog Liver Dis 14:131-159

    PubMed  CAS  Google Scholar 

  • Kato A, Yoshidome H, Edwards MJ, Lentsch AB (2000) Reduced hepatic ischemia/reperfusion injury by IL-4: potential anti-inflammatory role of STAT6. Inflamm Res 49:275-279

    PubMed  CAS  Google Scholar 

  • Kato A, Okaya T, Lentsch AB (2003) Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury. Hepatology 37:304-312

    PubMed  CAS  Google Scholar 

  • Kellokumpu-Lehtinen P, Iisalo E, Nordman E (1989) Hepatotoxicity of paracetamol in combination with interferon and vinblastine. Lancet 1:1143

    PubMed  CAS  Google Scholar 

  • Khan FD, Roychowdhury S, Gaspari AA, Svensson CK (2006) Immune response to xenobiotics in the skin: from contact sensitivity to drug allergy. Expert Opin Drug Metab Toxicol 2:261-272

    PubMed  CAS  Google Scholar 

  • Kleinschmidt WJ, Schultz RM (1982) Similarities of murine gamma interferon and the lymphokine that renders macrophages cytotoxic. J Interferon Res 2:291-299

    PubMed  CAS  Google Scholar 

  • Knolle PA, Uhrig A, Hegenbarth S, Loser E, Schmitt E, Gerken G, Lohse AW (1998) IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 114:427-433

    PubMed  CAS  Google Scholar 

  • Kobayashi S, Nishihira J, Watanabe S, Todo S (1999) Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide. Hepatology 29:1752-1759

    PubMed  CAS  Google Scholar 

  • Kollias G, Kontoyiannis D (2002) Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev 13:315-321

    PubMed  CAS  Google Scholar 

  • Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R (2001) Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 276:26605-26613

    PubMed  CAS  Google Scholar 

  • Kretz-Rommel A, Duncan SR, Rubin RL (1997) Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus. J Clin Invest 99:1888-1896

    PubMed  CAS  Google Scholar 

  • Kroemer G, Hirsch F, Gonzalez-Garcia A, Martinez C (1996) Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity 24:25-33

    PubMed  CAS  Google Scholar 

  • Kuby J (1997) Immunology, 3rd edn. W. H. Freeman & Company, New York

    Google Scholar 

  • La Flamme AC, Patton EA, Bauman B, Pearce EJ (2001) IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis. J Immunol 166:1903-1911

    PubMed  Google Scholar 

  • Lacour S, Gautier JC, Pallardy M, Roberts R (2005) Cytokines as potential biomarkers of liver toxicity. Cancer Biomark 1:29-39

    PubMed  CAS  Google Scholar 

  • Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson IV (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314-2317

    PubMed  CAS  Google Scholar 

  • Le Moine O, Louis H, Sermon F, Goldman M, Deviere J (1999) Interleukin-10 and liver diseases. Acta Gastroenterol Belg 62:1-8

    PubMed  Google Scholar 

  • Leeder JS, Kearns GL (1997) Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am 44:55-77

    PubMed  CAS  Google Scholar 

  • Leifeld L, Dumoulin FL, Purr I, Janberg K, Trautwein C, Wolff M, Manns MP, Sauerbruch T, Spengler U (2003) Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol 199:335-344

    PubMed  CAS  Google Scholar 

  • Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ (1998) Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology 27:507-512

    PubMed  CAS  Google Scholar 

  • Liew FY, Li Y, Millott S (1990) Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 71:556-559

    PubMed  CAS  Google Scholar 

  • Lim S, Crawley E, Woo P, Barnes PJ (1998) Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 352:113

    PubMed  CAS  Google Scholar 

  • Liu ZX, Kaplowitz N (2002) Immune-mediated drug-induced liver disease. Clin Liver Dis 6:755-774

    PubMed  Google Scholar 

  • Liu ZX, Kaplowitz N (2006) Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2:493-503

    PubMed  CAS  Google Scholar 

  • Liu SF, Ye X, Malik AB (1999) Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation 100:1330-1337

    PubMed  CAS  Google Scholar 

  • Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500-508

    PubMed  CAS  Google Scholar 

  • Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, Van den Berg K, Demols A, Goldman M, Le Moine O, Geerts A, Deviere J (1998) Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 28:1607-1615

    PubMed  CAS  Google Scholar 

  • Louis H, Le Moine O, Goldman M, Deviere J (2003) Modulation of liver injury by interleukin-10. Acta Gastroenterol Belg 66:7-14

    PubMed  CAS  Google Scholar 

  • Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650-659

    PubMed  CAS  Google Scholar 

  • Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J (2002) Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4:449-460

    PubMed  CAS  Google Scholar 

  • Lukacs NW, Strieter RM, Elner VM, Evanoff HL, Burdick M, Kunkel SL (1994) Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 alpha during monocyte-endothelial cell interactions. Blood 83:1174-1178

    PubMed  CAS  Google Scholar 

  • Lukacs NW, Strieter RM, Elner V, Evanoff HL, Burdick MD, Kunkel SL (1995) Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood 86:2767-2773

    PubMed  CAS  Google Scholar 

  • Luster MI, Simeonova PP, Gallucci RM, Bruccoleri A, Blazka ME, Yucesoy B, Matheson JM (2000) The role of tumor necrosis factor alpha in chemical-induced hepatotoxicity. Ann N Y Acad Sci 919:214-220

    PubMed  CAS  Google Scholar 

  • Ma XC, Xin J, Wang HX, Zhang T, Tu ZH (2003) Acute effects of huperzine A and tacrine on rat liver. Acta Pharmacol Sin 24:247-250

    PubMed  CAS  Google Scholar 

  • Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S, Senices M, Gill D, Dunussi-Joannopoulos K, Collins M, Nickerson-Nutter C, Fouser LA, Young DA (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118:597-607

    PubMed  CAS  Google Scholar 

  • Maltby J, Wright S, Bird G, Sheron N (1996) Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology 24:1156-1160

    PubMed  CAS  Google Scholar 

  • Masson MJ, Uetrecht JP (2004) Tolerance induced by low dose D-penicillamine in the brown Norway rat model of drug-induced autoimmunity is immune-mediated. Chem Res Toxicol 17:82-94

    PubMed  CAS  Google Scholar 

  • Masubuchi Y, Bourdi M, Reilly TP, Graf ML, George JW, Pohl LR (2003) Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun 304:207-212

    PubMed  CAS  Google Scholar 

  • Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045

    PubMed  CAS  Google Scholar 

  • Mayorga C, Pena RR, Blanca-Lopez N, Lopez S, Martin E, Torres MJ (2006) Monitoring the acute phase response in non-immediate allergic drug reactions. Curr Opin Allergy Clin Immunol 6:249-257

    PubMed  CAS  Google Scholar 

  • Mitchell JA, Gillam EM, Stanley LA, Sim E (1990) Immunotoxic side-effects of drug therapy. Drug Saf 5:168-178

    PubMed  CAS  Google Scholar 

  • Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765

    PubMed  CAS  Google Scholar 

  • Morio LA, Chiu H, Sprowles KA, Zhou P, Heck DE, Gordon MK, Laskin DL (2001) Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol 172:44-51

    PubMed  CAS  Google Scholar 

  • Murata H, Shimizu Y, Okada K, Higuchi K, Watanabe A (2003) Detection and analysis of intracytoplasmic cytokines in peripheral blood mononuclear cells in patients with drug-induced liver injury. J Hepatol 38:573-582

    PubMed  CAS  Google Scholar 

  • Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK (2003) Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 63:732-741

    PubMed  CAS  Google Scholar 

  • Naisbitt DJ, Pirmohamed M, Park BK (2007) Immunological principles of T-cell-mediated adverse drug reactions in skin. Expert Opin Drug Saf 6:109-124

    PubMed  CAS  Google Scholar 

  • Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC (2004a) Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 114:1209-1215

    PubMed  CAS  Google Scholar 

  • Nassif A, Moslehi H, Le Gouvello S, Bagot M, Lyonnet L, Michel L, Boumsell L, Bensussan A, Roujeau JC (2004b) Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol 123:850-855

    PubMed  CAS  Google Scholar 

  • Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17:701-738

    PubMed  CAS  Google Scholar 

  • Noguchi E, Shibasaki M, Arinami T, Takeda K, Yokouchi Y, Kawashima T, Yanagi H, Matsui A, Hamaguchi H (1998) Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 28:449-453

    PubMed  CAS  Google Scholar 

  • Ochel M, Vohr HW, Pfeiffer C, Gleichmann E (1991) IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 146:3006-3011

    PubMed  CAS  Google Scholar 

  • Olsen NJ (2004) Drug-induced autoimmunity. Best Pract Res Clin Rheumatol 18:677-688

    PubMed  CAS  Google Scholar 

  • Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28:454-467

    PubMed  CAS  Google Scholar 

  • Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher A, Morse HC 3 rd, Liu C, Schwartzberg PL, Leonard WJ (2002) A critical role for IL-21 in regulating immunoglobulin production. Science 298:1630-1634

    PubMed  CAS  Google Scholar 

  • Pai MP, Norenberg JP, Telepak RA, Sidney DS, Yang S (2005) Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate. Antimicrob Agents Chemother 49:3784-3788

    PubMed  CAS  Google Scholar 

  • Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Pierard GE (1994) Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 130:605-608

    PubMed  CAS  Google Scholar 

  • Paul WE (2003) Fundamental immunology, 5th edn. Lippencott, Williams & Wilkins, Philadelphia

    Google Scholar 

  • Pessayre D (1995) Role of reactive metabolites in drug-induced hepatitis. J Hepatol 23(Suppl 1):16-24

    PubMed  CAS  Google Scholar 

  • Pichler WJ (2006) Adverse side-effects to biological agents. Allergy 61:912-920

    PubMed  CAS  Google Scholar 

  • Pichler WJ, Zanni M, von Greyerz S, Schnyder B, Mauri-Hellweg D, Wendland T (1997) High IL-5 production by human drug-specific T cell clones. Int Arch Allergy Immunol 113:177-180

    PubMed  CAS  Google Scholar 

  • Piguet PF, Grau GE, Hauser C, Vassalli P (1991) Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 173:673-679

    PubMed  CAS  Google Scholar 

  • Pirmohamed M, Lin K, Chadwick D, Park BK (2001) TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients. Neurology 56:890-896

    PubMed  CAS  Google Scholar 

  • Popovic M, Caswell JL, Mannargudi B, Shenton JM, Uetrecht JP (2006) Study of the sequence of events involved in nevirapine-induced skin rash in Brown Norway rats. Chem Res Toxicol 19:1205-1214

    PubMed  CAS  Google Scholar 

  • Posadas SJ, Torres MJ, Mayorga C, Juarez C, Blanca M (2002) Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs. Blood Cells Mol Dis 29:179-189

    PubMed  Google Scholar 

  • Pumford NR, Myers TG, Davila JC, Highet RJ, Pohl LR (1993) Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac. Chem Res Toxicol 6:147-150

    PubMed  CAS  Google Scholar 

  • Qasim FJ, Thiru S, Gillespie K (1997) Gold and D-penicillamine induce vasculitis and up-regulate mRNA for IL-4 in the Brown Norway rat: support for a role for Th2 cell activity. Clin Exp Immunol 108:438-445

    PubMed  CAS  Google Scholar 

  • Qiao HL, Yang J, Zhang YW (2005) Relationships between specific serum IgE, cytokines and polymorphisms in the IL-4, IL-4Ralpha in patients with penicillins allergy. Allergy 60:1053-1059

    PubMed  CAS  Google Scholar 

  • Qiao HL, Wen Q, Gao N, Tian X, Jia LJ (2007) Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients. Eur J Clin Pharmacol 63:263-269

    PubMed  CAS  Google Scholar 

  • Quddus J, Johnson KJ, Gavalchin J, Amento EP, Chrisp CE, Yung RL, Richardson BC (1993) Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 92:38-53

    PubMed  CAS  Google Scholar 

  • Ren X, Carpenter A, Hogaboam C, Colletti L (2003) Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am J Pathol 163:563-570

    PubMed  CAS  Google Scholar 

  • Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T (2002) Differential regulation of interleukin-10 production by genetic and environmental factors - a twin study. Genes Immun 3:407-413

    PubMed  CAS  Google Scholar 

  • Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A (2005) Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204:27-42

    PubMed  CAS  Google Scholar 

  • Rogers PD, Jenkins JK, Chapman SW, Ndebele K, Chapman BA, Cleary JD (1998) Amphotericin B activation of human genes encoding for cytokines. J Infect Dis 178:1726-1733

    PubMed  CAS  Google Scholar 

  • Rogers PD, Stiles JK, Chapman SW, Cleary JD (2000) Amphotericin B induces expression of genes encoding chemokines and cell adhesion molecules in the human monocytic cell line THP-1. J Infect Dis 182:1280-1283

    PubMed  CAS  Google Scholar 

  • Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L (1995) Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25(Suppl 2):74-78; discussion 95-96

    Google Scholar 

  • Roujeau JC (2006) Immune mechanisms in drug allergy. Allergol Int 55:27-33

    PubMed  CAS  Google Scholar 

  • Roujeau JC, Stern RS (1994) Severe adverse cutaneous reactions to drugs. N Engl J Med 331:1272-1285

    PubMed  CAS  Google Scholar 

  • Roychowdhury S, Svensson CK (2005) Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J 7:E834-E846

    PubMed  CAS  Google Scholar 

  • Rubtsov YP, Rudensky AY (2007) TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol 7:443-453

    PubMed  CAS  Google Scholar 

  • Salminen WF Jr, Voellmy R, Roberts SM (1997) Protection against hepatotoxicity by a single dose of amphetamine: the potential role of heat shock protein induction. Toxicol Appl Pharmacol 147:247-258

    PubMed  CAS  Google Scholar 

  • Saoudi A, Kuhn J, Huygen K, de Kozak Y, Velu T, Goldman M, Druet P, Bellon B (1993) TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol 23:3096-3103

    PubMed  CAS  Google Scholar 

  • Satoh J, Seino H, Abo T, Tanaka S, Shintani S, Ohta S, Tamura K, Sawai T, Nobunaga T, Oteki T et al (1989) Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 84:1345-1348

    PubMed  CAS  Google Scholar 

  • Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM (2003) The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 278:37561-37568

    PubMed  CAS  Google Scholar 

  • Sayeh E, Uetrecht JP (2001) Factors that modify penicillamine-induced autoimmunity in Brown Norway rats: failure of the Th1/Th2 paradigm. Toxicology 163:195-211

    PubMed  CAS  Google Scholar 

  • Seder RA, Ahmed R (2003) Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 4:835-842

    PubMed  CAS  Google Scholar 

  • Segal R, Dayan M, Zinger H, Mozes E (2001) Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline. Lupus 10:23-31

    PubMed  CAS  Google Scholar 

  • Selzner M, Camargo CA, Clavien PA (1999) Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 30:469-475

    PubMed  CAS  Google Scholar 

  • Shaw PJ, Hopfensperger MJ, Ganey PE, Roth RA (2007) Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. Toxicol Sci 100:259-266

    PubMed  CAS  Google Scholar 

  • Shenton JM, Popovic M, Chen J, Masson MJ, Uetrecht JP (2005) Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat. Chem Res Toxicol 18:1799-1813

    PubMed  CAS  Google Scholar 

  • Simpson KJ, Lukacs NW, McGregor AH, Harrison DJ, Strieter RM, Kunkel SL (2000) Inhibition of tumour necrosis factor alpha does not prevent experimental paracetamol-induced hepatic necrosis. J Pathol 190:489-494

    PubMed  CAS  Google Scholar 

  • Sobel DO, Ewel CH, Zeligs B, Abbassi V, Rossio J, Bellanti JA (1994) Poly I:C induction of alpha-interferon in the diabetes-prone BB and normal Wistar rats. Dose-response relationships. Diabetes 43:518-522

    PubMed  CAS  Google Scholar 

  • Stachlewitz RF, Arteel GE, Raleigh JA, Connor HD, Mason RP, Thurman RG (1997) Development and characterization of a new model of tacrine-induced hepatotoxicity: role of the sympathetic nervous system and hypoxia-reoxygenation. J Pharmacol Exp Ther 282:1591-1599

    PubMed  CAS  Google Scholar 

  • Stordeur P, Goldman M (1998) Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects. Int Rev Immunol 16:501-522

    PubMed  CAS  Google Scholar 

  • Sullivan JR, Shear NH (2001) The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 137:357-364

    PubMed  CAS  Google Scholar 

  • Sun Y, Tokushige K, Isono E, Yamauchi K, Obata H (1992) Elevated serum interleukin-6 levels in patients with acute hepatitis. J Clin Immunol 12:197-200

    PubMed  CAS  Google Scholar 

  • Taub R (2003) Hepatoprotection via the IL-6/Stat3 pathway. J Clin Invest 112:978-980

    PubMed  CAS  Google Scholar 

  • Terry CF, Loukaci V, Green FR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138-18144

    PubMed  CAS  Google Scholar 

  • Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD (1998) Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 111:645-649

    PubMed  CAS  Google Scholar 

  • Tournade H, Pelletier L, Pasquier R, Vial MC, Mandet C, Druet P (1990) D-penicillamine-induced autoimmunity in Brown-Norway rats. Similarities with HgCl2-induced autoimmunity. J Immunol 144:2985-2991

    PubMed  CAS  Google Scholar 

  • Tracey KJ, Cerami A (1993) Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9:317-343

    PubMed  CAS  Google Scholar 

  • Tukov FF, Luyendyk JP, Ganey PE, Roth RA (2007) The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury. Toxicol Sci 100:267-280

    PubMed  CAS  Google Scholar 

  • Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8

    PubMed  CAS  Google Scholar 

  • Uetrecht JP (1999) New concepts in immunology relevant to idiosyncratic drug reactions: the “danger hypothesis” and innate immune system. Chem Res Toxicol 12:387-395

    PubMed  CAS  Google Scholar 

  • Ungo JR, Jones D, Ashkin D, Hollender ES, Bernstein D, Albanese AP, Pitchenik AE (1998) Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med 157:1871-1876

    PubMed  CAS  Google Scholar 

  • Vandebriel RJ, Van Och FM, van Loveren H (2005) In vitro assessment of sensitizing activity of low molecular weight compounds. Toxicol Appl Pharmacol 207:142-148

    PubMed  Google Scholar 

  • Villada G, Roujeau JC, Clerici T, Bourgault I, Revuz J (1992) Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch Dermatol 128:50-53

    PubMed  CAS  Google Scholar 

  • Wang YH, Liu YJ (2008) The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol 20:697-702

    PubMed  CAS  Google Scholar 

  • Weber RW (2004) Adverse reactions to biological modifiers. Curr Opin Allergy Clin Immunol 4:277-283

    PubMed  Google Scholar 

  • Weber LW, Boll M, Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105-136

    PubMed  CAS  Google Scholar 

  • Williams AM, Langley PG, Osei-Hwediah J, Wendon JA, Hughes RD (2003) Hyaluronic acid and endothelial damage due to paracetamol-induced hepatotoxicity. Liver Int 23:110-115

    PubMed  CAS  Google Scholar 

  • Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36:1309-1323

    PubMed  CAS  Google Scholar 

  • Wood N, Bourque K, Donaldson DD, Collins M, Vercelli D, Goldman SJ, Kasaian MT (2004) IL-21 effects on human IgE production in response to IL-4 or IL-13. Cell Immunol 231:133-145

    PubMed  CAS  Google Scholar 

  • Xu H, DiIulio NA, Fairchild RL (1996) T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 183:1001-1012

    PubMed  CAS  Google Scholar 

  • Yamada Y, Fausto N (1998) Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 152:1577-1589

    PubMed  CAS  Google Scholar 

  • Yamano T, Higashi T, Nouso K, Nakatsukasa H, Kariyama K, Yumoto E, Kobayashi Y, Yamamoto K, Iwagaki H, Yagi T, Tanimoto T, Kurimoto M, Tanaka N, Tsuji T (2000) Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis. Clin Exp Immunol 122:227-231

    PubMed  CAS  Google Scholar 

  • Yang J, Qiao HL, Dong ZM (2005) Polymorphisms of IL-13 and IL-4-IL-13-SNPs in patients with penicillin allergies. Eur J Clin Pharmacol 61:803-809

    PubMed  CAS  Google Scholar 

  • Yee SB, Bourdi M, Masson MJ, Pohl LR (2007) Hepatoprotective role of endogenous interleukin-13 in a murine model of acetaminophen-induced liver disease. Chem Res Toxicol 20:734-744

    PubMed  CAS  Google Scholar 

  • You Q, Cheng L, Reilly TP, Wegmann D, Ju C (2006) Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology 44:1421-1431

    PubMed  CAS  Google Scholar 

  • Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC (1995) Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 154:3025-3035

    PubMed  CAS  Google Scholar 

  • Zamara E, Galastri S, Aleffi S, Petrai I, Aragno M, Mastrocola R, Novo E, Bertolani C, Milani S, Vizzutti F, Vercelli A, Pinzani M, Laffi G, LaVilla G, Parola M, Marra F (2007) Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. J Hepatol 46:230-238

    PubMed  CAS  Google Scholar 

  • Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA (2007) Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27:647-659

    PubMed  CAS  Google Scholar 

  • Zisman DA, Kunkel SL, Strieter RM, Tsai WC, Bucknell K, Wilkowski J, Standiford TJ (1997) MCP-1 protects mice in lethal endotoxemia. J Clin Invest 99:2832-2836

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mary Jane Masson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Masson, M.J., Collins, L.A., Pohl, L.R. (2010). The Role of Cytokines in the Mechanism of Adverse Drug Reactions. In: Uetrecht, J. (eds) Adverse Drug Reactions. Handbook of Experimental Pharmacology, vol 196. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00663-0_8

Download citation

Publish with us

Policies and ethics